---
title: "Aster DM Quality Care Ltd (ASTERDM) — Share Price, Financials & Analysis"
symbol: "ASTERDM"
company: "Aster DM Quality Care Ltd"
canonical: "https://tapetide.com/stocks/ASTERDM"
isin: "INE914M01019"
nse_symbol: "ASTERDM"
bse_code: "540975"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 66373.5
generated_at: "2026-09-13T19:57:00.950Z"
---

# Aster DM Quality Care Ltd (ASTERDM)

Canonical page: https://tapetide.com/stocks/ASTERDM

## Company

- **NSE Symbol:** ASTERDM
- **BSE Code:** 540975
- **ISIN:** INE914M01019
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2018-02-26
- **CEO:** Dr. Mandayapurath Azad Moopen DTCD, M.D., MBBS
- **Employees:** 15334
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** asterdmhealthcare.in

## About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

## Latest Price

- **Price:** ₹763.05
- **Change:** -3.45 (-0.45%)
- **Open:** ₹761
- **Day High:** ₹770.9
- **Day Low:** ₹757.55
- **Previous Close:** ₹766.5
- **Volume:** 600395
- **As Of:** 2026-09-11T10:25:45+00:00

## Key Fundamentals

Observed at 2026-09-11T04:49:53.148259Z.

- **Market Cap:** ₹66373.5 Cr
- **Classification:** Midcap
- **P/E (reported):** 184.3
- **P/E (TTM):** 124.07
- **EPS (TTM):** ₹6.15
- **EPS (reported):** ₹2.47
- **Book Value:** ₹48.26
- **Price to Book:** 15.89
- **Dividend Yield:** 0.39%
- **ROE:** 8.84%
- **ROCE:** 9.71%
- **Debt to Equity:** 0.62
- **Revenue (yearly):** ₹4768.8 Cr
- **Net Income:** ₹427.1 Cr
- **EBITDA:** ₹1026.6 Cr
- **52-Week High:** ₹891.3
- **52-Week Low:** ₹519.1
- **RSI (14):** 42.23

## Tapetide Score

- **Score:** 35 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 38.46 | 9% |
| growth | 44.19 | 9% |
| momentum | 38.43 | 12% |
| ownership | 47.18 | 24% |
| quality | 38.02 | 22% |
| valuation | 23.17 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has been maintaining a healthy dividend payout of 1,560%
- Promoter holding has increased by 13.3% over last quarter.

### Weaknesses

- Stock is trading at 9.41 times its book value
- Company has a low return on equity of 6.30% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 54.32% | 315.64% | -50.08% |
| ebitda margin growth | -31.47% | 1.13% | 32.98% | 44.59% |
| net income growth | -80.92% | 26.85% | -1% | 23% |
| revenue growth | 10.57% | 11.25% | 16% | -12% |
| roce | -43.47% | -6.54% | 75.27% | 7.67% |
| roe | -80.94% | -4.12% | 7.38% | -34.08% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 929 | 955 | 974 | 1002 | 1086 | 1050 | 1000 | 1078 | 1197 | 1186 | 1182 | 1311 |
| Expenses | 787 | 805 | 817 | 841 | 869 | 864 | 818 | 876 | 961 | 983 | 958 | 1055 |
| Operating Profit | 142 | 149 | 156 | 161 | 217 | 186 | 182 | 202 | 236 | 202 | 224 | 256 |
| OPM % | 15 | 16 | 16 | 16 | 20 | 18 | 18 | 19 | 20 | 17 | 19 | 20 |
| Other Income | -64 | 153 | -40 | 5120 | 35 | 9 | 5 | 29 | 28 | 0 | 37 | -77 |
| Interest | 30 | 25 | 30 | 29 | 31 | 31 | 32 | 31 | 31 | 31 | 30 | 31 |
| Depreciation | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 | 67 | 69 |
| Profit before tax | -7 | 220 | 28 | 5191 | 159 | 102 | 91 | 136 | 167 | 103 | 163 | 78 |
| Tax % | 120 | 5 | 108 | 1 | 33 | 37 | 6 | 31 | 27 | 43 | 6 | 62 |
| Net Profit | -15 | 209 | -2 | 5152 | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 |
| EPS in Rs | -0.62 | 3.59 | -0.48 | 103 | 1.94 | 1.14 | 1.58 | 1.65 | 2.12 | 1.01 | 2.71 | 0.31 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6721 | 7963 | 8652 | 8608 | 10253 | 2994 | 3699 | 4138 | 4643 | 4876 |
| Expenses | 6089 | 6886 | 7187 | 7506 | 8720 | 2547 | 3124 | 3383 | 3769 | 3958 |
| Operating Profit | 632 | 1077 | 1465 | 1103 | 1533 | 447 | 575 | 756 | 875 | 918 |
| OPM % | 9 | 14 | 17 | 13 | 15 | 15 | 16 | 18 | 19 | 19 |
| Other Income | 177 | -155 | -158 | 53 | 51 | 353 | 32 | 5168 | 91 | -13 |
| Interest | 204 | 205 | 391 | 334 | 307 | 96 | 119 | 133 | 132 | 123 |
| Depreciation | 298 | 306 | 586 | 618 | 641 | 192 | 220 | 249 | 264 | 270 |
| Profit before tax | 308 | 410 | 330 | 205 | 637 | 511 | 268 | 5542 | 570 | 511 |
| Tax % | 8 | 10 | 5 | 13 | 6 | 7 | 21 | 2 | 25 | — |
| Net Profit | 282 | 367 | 315 | 178 | 601 | 475 | 212 | 5408 | 427 | 363 |
| EPS in Rs | 5.32 | 6.59 | 5.54 | 2.96 | 10.53 | 8.51 | 2.59 | 107.66 | 7.49 | 6.15 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 4637 | 5 | 40 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 | 518 |
| Reserves | 1472 | 2327 | 2709 | 2775 | 2875 | 3080 | 3574 | 3686 | 2554 | 3683 |
| Borrowings | 2758 | 2352 | 2788 | 5605 | 4804 | 5282 | 6075 | 1758 | 2392 | 2594 |
| Other Liabilities | 2171 | 2296 | 2926 | 3528 | 3444 | 3661 | 4687 | 12039 | 1154 | 1280 |
| Total Liabilities | 6804 | 7479 | 8928 | 12405 | 11620 | 12521 | 14836 | 17983 | 6600 | 8076 |
| Fixed Assets | 3520 | 3738 | 4289 | 7124 | 6749 | 7009 | 9052 | 3175 | 3920 | 4242 |
| CWIP | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 | 420 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 | 1167 |
| Other Assets | 2962 | 3302 | 4067 | 4511 | 3874 | 4470 | 5425 | 14620 | 2142 | 2248 |
| Total Assets | 6804 | 7479 | 8928 | 12405 | 11620 | 12521 | 14836 | 17983 | 6600 | 8076 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 361 | 537 | 601 | 1223 | 1569 | 1314 | 1834 | 158 | 425 | 656 |
| Cash from Investing Activity | -1136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6015 | -288 |
| Cash from Financing Activity | 654 | 46 | 134 | -675 | -1116 | -686 | -817 | 1053 | -6358 | -304 |
| Net Cash Flow | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 | 63 |
| Free Cash Flow | -565 | 23 | 64 | 715 | 1183 | 770 | 995 | -601 | 70 | 179 |
| CFO/OP | 116 | 93 | 61 | 88 | 143 | 89 | 424 | 40 | 71 | 93 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 79 | 84 | 93 | 100 | 86 | 72 | 285 | 23 | 23 | 24 |
| Inventory Days | 102 | 111 | 110 | 138 | 122 | 129 | 612 | 44 | 36 | 32 |
| Days Payable | 151 | 150 | 153 | 303 | 290 | 267 | 1400 | 183 | 166 | 168 |
| Cash Conversion Cycle | 30 | 45 | 50 | -65 | -83 | -66 | -503 | -116 | -107 | -112 |
| Working Capital Days | 6 | 59 | 28 | 8 | 5 | 5 | -21 | 272 | -32 | -28 |
| ROCE % | 1 | 7 | 13 | 12 | 6 | 10 | 3 | 4 | 11 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 41.88% | 41.88% | 41.88% | 41.88% | 41.88% | 41.88% | 41.89% | 40.39% | 40.39% | 40.39% | 40.39% | 40.39% |
| FIIs | 40.21% | 29.09% | 33.48% | 27.08% | 23.85% | 22.62% | 21.66% | 19.64% | 18.72% | 18.46% | 17.18% | 10.53% |
| DIIs | 7.64% | 7.15% | 13.7% | 16.35% | 20.91% | 22.91% | 24.59% | 25.28% | 26.32% | 26.12% | 27.58% | 27.65% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 3.15% | 2.96% | 3.09% | 6.98% | 5.94% | 5.04% | 4.38% | 3.94% | 3.86% | 4.07% | 3.93% | 3.71% |
| Others | 7.11% | 18.93% | 7.85% | 7.72% | 7.42% | 7.55% | 7.49% | 10.76% | 10.7% | 10.95% | 10.91% | 17.72% |
| No. of Shareholders | 67673 | 67331 | 80931 | 206660 | 174171 | 159038 | 154014 | 148139 | 147304 | 146998 | 136892 | 133444 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 7 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 774.24 | Sell |
| EMA (10) | 774.69 | Sell |
| SMA (20) | 774.45 | Sell |
| EMA (20) | 780.5 | Sell |
| SMA (50) | 800.41 | Sell |
| EMA (50) | 786 | Sell |
| SMA (100) | 776.92 | Sell |
| EMA (100) | 766.34 | Sell |
| SMA (200) | 701.47 | Buy |
| EMA (200) | 718.46 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.08 | Neutral |
| MACD (12,26,9) | -8.09 | Buy |
| Stochastic (14,3,3) | 47.36 | Neutral |
| ADX (14) | 17.81 | Neutral |
| Williams %R (14) | -65.3 | Neutral |
| ATR (14) | 21.05 | Neutral |
| ROC (12) | 0.12 | Buy |
| Stoch RSI (14) | 41.94 | Neutral |
| UO (7,14,28) | 54.84 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 9 | 81.82% |
| Hold | 1 | 9.09% |
| Sell | 1 | 9.09% |

Based on 11 analyst ratings, observed at 2026-09-11T04:49:53.326589+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30BF6B2F_78C9_4476_80D1_46C89409043E_090548.pdf) |
| 2026-09-09 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5217B83B_1AB3_424D_AA83_904C1D2D1980_120620.pdf) |
| 2026-09-09 | [Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3B155A8D_E1BF_4818_A4FC_DF27AD0B9D2E_120630.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=513e6735-e9ea-489e-9461-a3155a0b71bc.pdf) |
| 2026-09-05 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80f9684d-18da-4cbb-9940-7478052c9829.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=072b5ded-dcf1-426f-a124-c7710541ba1a.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c224a4f-1cf9-4526-8caf-dd2d6d10800f.pdf) |
| 2026-09-04 | [Notice Of The 18Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=915d610e-ca8e-40f8-bd7f-81d42c1d68eb.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6944c611-bd17-45ed-a3b9-81caaaf33cc3.pdf) |
| 2026-08-31 | [Regulation 30 Read With Part B Of Schedule III To The SEBI Listing Regulations - Capacity Expansion At The Facility Of A Material Subsidiary Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=229e611d-2f40-45e8-855a-ebbfd6fc29ad.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ed42b2f-0e31-4dc1-9602-0684cf5dca18.pdf) |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=199c44ba-0dff-413b-84de-872f67a011a0.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caa879ae-8f7c-4280-8e22-e09387565d78.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e6957fa-1a95-4515-b3bc-46fa27df17bf.pdf) |
| 2025-08-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e334a7a-3e9d-49d5-b7cd-27bbdb00b570.pdf) |
| 2025-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e03ce0d1-daf7-4f77-9df1-628f8f5ee9fa.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=990f551c-0d41-4ac3-995c-b773e1b405dc.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-05 | [Unaudited Financial Results (Standalone And Consolidated) For The First Quarter Ended 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d830e70-c08a-47e0-a950-640f1445bb27.pdf) |
| 2026-04-30 | [Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de3ae2ae-ab24-49c0-900c-b800a3d87a3c.pdf) |
| 2025-11-06 | [Results - Financial Results For Sep 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=061f35c0-4608-4b33-b303-b7f093db9cd1.pdf) |
| 2025-07-30 | [Results-Financial Results For Jun 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18eba4c2-52b9-43cf-814a-35e499b9ab7c.pdf) |
| 2025-01-31 | [Unaudited Financial Results For The Quarter Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c186a516-7d5e-4ae0-b000-eff9ae8a7f3c.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29910f35-9ac7-4f00-8094-f9b63da6cad6.pdf) |
| 2026-06-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f450d98-249a-427f-8388-39c76d338862.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ace7e196-b0e8-4a27-93f9-9479f755ae29.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00c944b6-a342-449a-ba3a-324c9b3da7c0.pdf) |
| 2026-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f1ce99a-22b5-49bb-973b-c9ff36eaad02.pdf) |
| 2025-11-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64ec6fd2-b04e-4ec7-ab98-c956bb43a5c0.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e2f4a3e-4291-4b8a-a9df-78dda3cd0c6b.pdf) |
| 2025-07-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4644b7d9-145d-4727-943f-bc2cc689c11c.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba2f84ac-950b-4dbc-b81b-1c3c494cf137.pdf) |
| 2025-01-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6deb0860-63ff-400b-865f-8a04088452bd.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00d1f68a-c700-4575-bdda-ce99ae75dc72.pdf) |
| 2026-05-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f28d393-ef87-4a39-8e06-29432bee18e3.pdf) |
| 2024-11-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=302000cb-2b8a-48c0-bd89-4392e45c0b92.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e2f4a3e-4291-4b8a-a9df-78dda3cd0c6b.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6e6957fa-1a95-4515-b3bc-46fa27df17bf.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e03ce0d1-daf7-4f77-9df1-628f8f5ee9fa.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/199c44ba-0dff-413b-84de-872f67a011a0.pdf) |
| Jan 2026 | [Concall - Jan 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f1ce99a-22b5-49bb-973b-c9ff36eaad02.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/caa879ae-8f7c-4280-8e22-e09387565d78.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/990f551c-0d41-4ac3-995c-b773e1b405dc.pdf) |
| Dec 2024 | [Concall - Dec 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1610bdfc-8be7-410b-9c13-4d8125c246e2.pdf) |
| Dec 2024 | [Concall - Dec 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1610bdfc-8be7-410b-9c13-4d8125c246e2.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6e334a7a-3e9d-49d5-b7cd-27bbdb00b570.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Earnings conference call scheduled for May 1, 2026 at 11:00 AM IST for Q4 and FY26 results. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9h - Earnings conference call scheduled for May 1, 2026 at 11:00 AM IST for Q4 and FY26 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/56d0f766-02ab-426d-bbdc-78c3300458b1.pdf) |
| 9h - 22,48,270 shares at Rs.285 each (approx. Rs.64.08 crore) allotment deferred; only 62.14% consideration received; acquisition deferred. | [Announcement under Regulation 30 (LODR)-Preferential Issue 9h - 22,48,270 shares at Rs.285 each (approx. Rs.64.08 crore) allotment deferred; only 62.14% consideration received; acquisition deferred.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7ab3f79d-630c-4a9b-b26f-9525d9ae04f7.pdf) |
| 8 May - Transcript of earning conference call held for quarter and year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 8 May - Transcript of earning conference call held for quarter and year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/199c44ba-0dff-413b-84de-872f67a011a0.pdf) |
| 7h - Aster DM Healthcare confirms it is not a Large Corporate; outstanding borrowing was Rs 304.22 crore as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 7h - Aster DM Healthcare confirms it is not a Large Corporate; outstanding borrowing was Rs 304.22 crore as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4310f39b-7943-4bb4-a53d-4367dd6a83af.pdf) |
| 5h - Unsecured creditors approved QCIL→Aster amalgamation on March 10, 2026; 100% votes (680,398,379). | [Unsecured Creditors Meeting - Scrutinizer''s Report And E-Voting Results 5h - Unsecured creditors approved QCIL→Aster amalgamation on March 10, 2026; 100% votes (680,398,379).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/87ca6855-7d9f-4f33-aded-a4d9a2170f7f.pdf) |
| 30 Apr - Q4 FY26 revenue rose 18%; merger with QCIL got 96.68% shareholder approval. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Q4 FY26 revenue rose 18%; merger with QCIL got 96.68% shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2aee8f4-a4ce-4bbc-a36a-2367f8cc05f4.pdf) |
| 30 Apr - Q4 FY26 revenue rose 18%; merger with QCIL got 96.68% shareholder approval. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Q4 FY26 revenue rose 18%; merger with QCIL got 96.68% shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c2aee8f4-a4ce-4bbc-a36a-2367f8cc05f4.pdf) |
| 30 Apr - Investor presentation for the earning conference calls scheduled for May 1, 2026, in related to audited financial results for the quarter and year ended March … | [Announcement under Regulation 30 (LODR)-Investor Presentation 30 Apr - Investor presentation for the earning conference calls scheduled for May 1, 2026, in related to audited financial results for the quarter and year ended March …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ace7e196-b0e8-4a27-93f9-9479f755ae29.pdf) |
| 30 Apr - Investor presentation for the earning conference calls scheduled for May 1, 2026, in related to audited financial results for the quarter and year ended March … | [Announcement under Regulation 30 (LODR)-Investor Presentation 30 Apr - Investor presentation for the earning conference calls scheduled for May 1, 2026, in related to audited financial results for the quarter and year ended March …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ace7e196-b0e8-4a27-93f9-9479f755ae29.pdf) |
| 30 Apr - Board approved audited Q4/FY26 standalone and consolidated results on 30 April 2026; auditors issued unmodified opinion. | [Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 30 Apr - Board approved audited Q4/FY26 standalone and consolidated results on 30 April 2026; auditors issued unmodified opinion.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de3ae2ae-ab24-49c0-900c-b800a3d87a3c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/247937ef-3f07-4225-8a34-77037ba24360.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/826d51a2-456b-4957-a031-cdb6f3674bd4.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:57:00.950Z.